Bank Of New York Mellon Corp Adma Biologics, Inc. Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$4.4 - $6.74 $277,151 - $424,545	-62,989 Reduced 8.08%	716,913 $4.73 Billion
Q4 2023 Jan 29, 2024	SELL	$3.08 - $4.52 $79,457 - $116,606	-25,798 Reduced 3.2%	779,902 $3.53 Billion
Q3 2023 Oct 24, 2023	BUY	$3.47 - $4.61 $57,431 - $76,300	16,551 Added 2.1%	805,700 $2.88 Billion
Q2 2023 Aug 03, 2023	BUY	$3.12 - $4.22 $353,623 - $478,299	113,341 Added 16.77%	789,149 $2.91 Billion
Q1 2023 May 09, 2023	BUY	$3.01 - $3.87 $2.03 Million - $2.62 Million	675,808 New	675,808 $2.24 Billion
Q4 2022 Feb 14, 2023	BUY	$2.47 - $3.88 $1.6 Million - $2.51 Million	647,880 New	647,880 $2.51 Million
Q3 2022 Nov 14, 2022	BUY	$2.03 - $2.86 $164,464 - $231,708	81,017 Added 16.21%	580,827 $1.41 Million
Q2 2022 Aug 15, 2022	BUY	$1.43 - $2.2 $595,464 - $916,099	416,409 Added 499.29%	499,810 $990,000
Q1 2022 May 11, 2022	BUY	$1.28 - $1.83 $47,317 - $67,649	36,967 Added 79.61%	83,401 $153,000
Q3 2021 Nov 12, 2021	SELL	$1.13 - $1.65 $15,047 - $21,971	-13,316 Reduced 22.29%	46,434 $52,000
Q2 2021 Aug 11, 2021	SELL	$1.51 - $2.07 $219,949 - $301,520	-145,662 Reduced 70.91%	59,750 $95,000
Q1 2021 May 13, 2021	SELL	$1.67 - $2.95 $5,616 - $9,920	-3,363 Reduced 1.61%	205,412 $361,000
Q4 2020 Feb 09, 2021	BUY	$1.8 - $2.56 $26,915 - $38,279	14,953 Added 7.71%	208,775 $407,000
Q3 2020 Nov 12, 2020	SELL	$2.04 - $3.74 $46,950 - $86,076	-23,015 Reduced 10.61%	193,822 $463,000
Q2 2020 Aug 12, 2020	BUY	$2.42 - $3.29 $56,102 - $76,272	23,183 Added 11.97%	216,837 $635,000
Q1 2020 May 06, 2020	BUY	$1.5 - $4.59 $48,001 - $146,884	32,001 Added 19.8%	193,654 $557,000
Q4 2019 Feb 14, 2020	BUY	$3.89 - $5.15 $108,534 - $143,690	27,901 Added 20.86%	161,653 $646,000
Q3 2019 Nov 07, 2019	BUY	$3.19 - $5.39 $164,527 - $277,994	51,576 Added 62.76%	133,752 $595,000
Q2 2019 Aug 12, 2019	BUY	$3.52 - $5.24 $75,838 - $112,895	21,545 Added 35.53%	82,176 $317,000
Q1 2019 May 14, 2019	BUY	$2.61 - $4.35 $15,145 - $25,243	5,803 Added 10.58%	60,631 $230,000
Q2 2018 Aug 06, 2018	BUY	$4.39 - $5.44 $157,122 - $194,703	35,791 Added 188.01%	54,828 $247,000
Q1 2018 May 15, 2018	BUY	$3.21 - $5.21 $61,108 - $99,182	19,037 New	19,037 $87,000

Others Institutions Holding ADMA

# of Institutions

319

Shares Held

185M

Call Options Held

917K

Put Options Held

91.6K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.85B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account